Canadian Pradaxa Acute Stroke Safety Study

Trial Profile

Canadian Pradaxa Acute Stroke Safety Study

Phase of Trial: Phase III

Latest Information Update: 31 Oct 2017

At a glance

  • Drugs Dabigatran etexilate (Primary)
  • Indications Ischaemic heart disorders; Stroke
  • Focus Therapeutic Use
  • Acronyms CPASS
  • Most Recent Events

    • 24 Oct 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2018.
    • 16 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top